Daniel Camardo
Board Member
Cue Biopharma, Inc. (CUE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Camardo
Daniel Camardo is recorded as Board Member at Cue Biopharma, Inc. (CUE). Cue Biopharma, Inc. reported in an 8-K filed June 2, 2026 that Daniel Camardo was appointed director, effective May 30, 2026.
“On May 30, 2026, the Board appointed each of Daniel Camardo and Viola Meehan as directors of the Company, to hold office for a one-year term and until his or her resignation or removal or his or her successors are duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-30–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cue Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel R. Passeri CEO, Board Member
- Dr. Shao-Lee Lin CEO, Board Member
- Lucinda Warren CEO, CFO
- Usman Azam CEO, Board Member
- James Ahlers CFO
- Kerri Millar CFO
- Colin G. Sandercock General Counsel
- Sumita Ray General Counsel
- Michael Meluzio Chief Accounting Officer
- Jill Broadfoot Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.